✦ LIBER ✦

Tumor necrosis factor-alpha converting enzyme: Implications for ocular inflammatory diseases

✍ Scribed by Kota V. Ramana

Book ID: 116307904
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 519 KB
Volume: 42
Category: Article
ISSN: 1357-2725
DOI: 10.1016/j.biocel.2010.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracellular maturation and transport o

Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme

✍ Franck Peiretti; Matthias Canault; Paule Deprez-Beauclair; Virginie Berthet; Ber 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Ocular inflammatory effects of intravitr

Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin

✍ Lloyd N. Fleisher; Jenny B. Ferrell; M. Christine McGahan 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 631 KB

Functional Analysis of the Domain Struct

Functional Analysis of the Domain Structure of Tumor Necrosis Factor-alpha Converting Enzyme

✍ Reddy, P. 📂 Article 📅 2000 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 221 KB

Serotonin stimulates platelet receptor s

Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17)

✍ D. DUERSCHMIED; M. CANAULT; D. LIEVENS; A. BRILL; S. M. CIFUNI; M. BADER; D. D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

A Continuous Fluorimetric Assay for Tumo

A Continuous Fluorimetric Assay for Tumor Necrosis Factor-α Converting Enzyme

✍ Guixian Jin; Xinyi Huang; Roy Black; Martin Wolfson; Charles Rauch; Herbert McGr 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Fluorogenic peptide substrates with fluorophore/ quencher-capped ends have found extensive use in monitoring protease activity in the screening of small-molecule libraries for protease inhibitors. We report here the identification and characterization of a fluorogenic substrate for tumor necrosis fa

Liver diseases associated with anti-tumo

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha